Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Cash from Operations (2017 - 2020)

enVVeno Medical has reported Cash from Operations over the past 4 years, most recently at 2613694.0 for Q4 2020.

  • Quarterly results put Cash from Operations at 2613694.0 for Q4 2020, down 61.02% from a year ago — trailing twelve months through Dec 2020 was 7677210.0 (down 30.2% YoY), and the annual figure for FY2025 was 15568000.0, up 7.54%.
  • Cash from Operations for Q4 2020 was 2613694.0 at enVVeno Medical, down from 2591648.0 in the prior quarter.
  • Over the last five years, Cash from Operations for NVNO hit a ceiling of 1152128.0 in Q1 2020 and a floor of 2613694.0 in Q4 2020.
  • Median Cash from Operations over the past 4 years was 1469127.0 (2018), compared with a mean of 1600712.79.
  • Peak annual rise in Cash from Operations hit 22.86% in 2020, while the deepest fall reached 91.97% in 2020.
  • enVVeno Medical's Cash from Operations stood at 1271211.0 in 2017, then fell by 13.65% to 1444699.0 in 2018, then fell by 12.36% to 1623221.0 in 2019, then crashed by 61.02% to 2613694.0 in 2020.
  • The last three reported values for Cash from Operations were 2613694.0 (Q4 2020), 2591648.0 (Q3 2020), and 1319740.0 (Q2 2020) per Business Quant data.